search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEWS


Coperion to deliver ZSK chemical recycling system


Coperion is to supply a ZSK Mc18 twin screw


extruder for a Plastics2Chemicals (P2C) plant that Belgian waste management company Indaver is building in Antwerp to convert 30,000 tonnes/yr of end-of-life plastics. Coperion says the ZSK extruder plays a central


role in the P2C depolymerisation process by preparing the waste plastic prior to feeding into the reactor. The contract includes supply of the ZSK extruder, plus Coperion K-Tron gravimetric feeders, vacuum unit, closing valve, and other peripherals. The P2C process breaks polymers into shorter carbon chains or monomers. Polyolefins can be convert- ed to naphtha and wax while polystyrenes can be split into monomers for reuse as raw material. �www.coperion.com


IMAGE: COPERION


IN BRIEF... Coperion’s ZSK extruder


will prepare plastics waste for chemical processing


Chemours, DuPont and Corteva agree PFAS settlement in US


Chemours, DuPont and Corteva have reached an agreement in principle to resolve all PFAS-related drinking water system pollution claims of a defined class of US public water systems (including systems with a current detection of PFAS1 at any level and those that are currently


required to monitor for the presence of PFAS under EPA monitoring rules or other applicable laws). The agreement would see the companies collec- tively contribute a total of $1.185bn to a settlement fund, with contribution rates consistent with a binding Memorandum of Under-


standing reached in January 2021. That will see Chem- ours contributing 50% percent and DuPont and Corteva the remaining 50%. Upon finalisation of a definitive agreement, expected within the second quarter of 2023, the settlement will be subject to final court approval.


Titanium dioxide and specialty materials com- pany Chemours an- nounced net sales for Q2 of 2023 of $1.6bn, down 14% year-on-year. Adjusted EBITDA was $324m, down 32%. The Titanium Tech- nologies business saw sales drop 27% to $707m and EBITDA drop 60% to $87m. It will close its TiO2 plant at Kuan Yin, Taiwan, saying the decision is part of a comprehensive strategy to optimise its manufacturing circuit. www.chemours.com


EU27 chemical production is expected to decline by about 8% in 2023 com- pared to the previous year with no imminent recovery of chemical demand in Europe likely, according to industry group Cefic. “The EU chemical industry is facing a perfect storm,” said Marco Mensink, Cefic Direc- tor General. “The combina- tion of high energy prices, lack of global demand and the US IRA means there is simply no business case for investing in Europe now.” https://cefic.org


Braskem ups bio-PE capacity at Triunfo


Brazilian petrochemical company Braskem has completed an $87m investment in its bio-based ethylene plant at its Triunfo complex at Rio Grande do Sul in Brazil, lifting its operating capacity by 30% to 260,000 tonnes/yr. The bio-based ethylene will be used to produce the company’s I’m green line of bio-based PE. “The expansion of bio-based ethylene capacity reinforces Braskem’s commitment to sustainable development and innovation and proves the success of the strategy we engaged in thirteen years ago, when we launched the world’s first bio-based polyethylene production at industrial scale,” said Walmir Soller, O/P VP for Europe and Asia responsible for the I’m greenbio-based business globally. �www.braskem.com


8 COMPOUNDING WORLD | August 2023 www.compoundingworld.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62